Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Short term Debt (2020 - 2025)

GoHealth's Short term Debt history spans 6 years, with the latest figure at $39.5 million for Q1 2025.

  • For Q1 2025, Short term Debt fell 47.33% year-over-year to $39.5 million; the TTM value through Mar 2025 reached $39.5 million, down 47.33%, while the annual FY2024 figure was $39.5 million, 47.33% down from the prior year.
  • Short term Debt for Q1 2025 was $39.5 million at GoHealth, roughly flat from $39.5 million in the prior quarter.
  • Across five years, Short term Debt topped out at $75.0 million in Q4 2023 and bottomed at $4.2 million in Q1 2021.
  • The 5-year median for Short term Debt is $5.3 million (2021), against an average of $26.2 million.
  • The largest annual shift saw Short term Debt surged 1323.15% in 2023 before it tumbled 47.33% in 2024.
  • A 5-year view of Short term Debt shows it stood at $5.3 million in 2021, then changed by 0.0% to $5.3 million in 2022, then soared by 1323.15% to $75.0 million in 2023, then crashed by 47.33% to $39.5 million in 2024, then changed by 0.0% to $39.5 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Short term Debt are $39.5 million (Q1 2025), $39.5 million (Q4 2024), and $65.0 million (Q3 2024).